<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03978169</url>
  </required_header>
  <id_info>
    <org_study_id>RC31/18/0379</org_study_id>
    <nct_id>NCT03978169</nct_id>
  </id_info>
  <brief_title>Pulmonary Impacts of Anaesthetic Modalities Evaluated by Ultrasound</brief_title>
  <acronym>PULCHO-KNEE</acronym>
  <official_title>Pulmonary Impacts of Anaesthetic Modalities Evaluated by Ultrasound: A Prospective Study in Scheduled Knee Arthroplasty</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Toulouse</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Toulouse</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      A prospective, observational, monocentric study aimed at identifying ultrasound changes in
      anaesthesia on the pulmonary parenchyma after knee arthroplastic surgery using the LUS score
      in the preoperative, immediate post-operative (D0) and late post-operative (D1) periods.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Post-operative pulmonary complications are responsible from morbidity and mortality close to
      cardiovascular complications.

      Perioperative and post-operative respiratory changes are secondary to anaesthesia (general
      anaesthesia, elongated position, tidal volume) and to surgery in particular abdominal and
      cardiothoracic surgery.

      Several risk factors related to patients were identified: age, ASA score&gt; 2, functional
      dependence, chronic obstructive pulmonary disease, congestive heart failure, obesity,
      smoking.

      Pulmonary ultrasound is a simple and rapid means of monitoring, widely used in resuscitation
      and developing in anaesthesia.

      The hypothesis of the study is that anaesthesia and / or ventilation is responsible for lung
      lesions observable by ultrasound from the recovery room, even after extra-thoracic surgeries.

      To do this, it will perform 3 pleuro-pulmonary ultrasound scans, preoperatively on the day of
      surgery, post-operatively in the recovery room and the day after surgery. LUS score will be
      calculated. Preoperative data (morphology, comorbidities), preoperative (ventilation,
      filling, position, type of anaesthesia - general anaesthesia with intubation or laryngeal
      mask, spinal anaesthesia- , type of surgery) and postoperative data (constants, oxygen
      therapy, complications) will be collected.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">December 13, 2018</start_date>
  <completion_date type="Anticipated">November 2020</completion_date>
  <primary_completion_date type="Anticipated">November 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>lung lesions by the anaesthetic and operative management after knee replacement surgery</measure>
    <time_frame>10 minutes before surgery</time_frame>
    <description>Describe lung lesions by the anaesthetic and operative management after knee replacement surgery</description>
  </primary_outcome>
  <primary_outcome>
    <measure>lung lesions by the anaesthetic and operative management after knee replacement surgery</measure>
    <time_frame>10 minutes post surgery</time_frame>
    <description>Describe lung lesions by the anaesthetic and operative management after knee replacement surgery</description>
  </primary_outcome>
  <primary_outcome>
    <measure>lung lesions by the anaesthetic and operative management after knee replacement surgery</measure>
    <time_frame>24hours post surgery</time_frame>
    <description>Describe lung lesions by the anaesthetic and operative management after knee replacement surgery</description>
  </primary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Anticipated">99</enrollment>
  <condition>Anesthesia</condition>
  <arm_group>
    <arm_group_label>General anaesthesia with orotracheal intubation</arm_group_label>
    <description>surgery patients under general anaesthesia with orotracheal intubation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>General anaesthesia with laryngeal mask</arm_group_label>
    <description>surgery patient under general anaesthesia with laryngeal mask</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Spinal anaesthesia</arm_group_label>
    <description>surgery's patients under Spinal anaesthesia</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>pleuropulmonary ultrasound</intervention_name>
    <description>three pleuro-pulmonary ultrasound scans will be performed, preoperatively on the day of surgery, post-operatively in the recovery room and the day after surgery</description>
    <arm_group_label>General anaesthesia with laryngeal mask</arm_group_label>
    <arm_group_label>General anaesthesia with orotracheal intubation</arm_group_label>
    <arm_group_label>Spinal anaesthesia</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patient undergoing scheduled primary knee arthroplasty
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patient undergoing scheduled primary knee arthroplasty :

          -  Partial knee replacement surgery

          -  Total knee replacement surgery

             â€¢ Type of Anaesthesia

          -  General anaesthesia with orotracheal intubation

          -  General anaesthesia with laryngeal mask

          -  Spinal anaesthesia

               -  Major Patient

               -  Oral non opposition collected after oral information of the study

        Exclusion Criteria:

          -  Refusal to participate

          -  Preoperative pleural pathology (pleural effusion, pleural symphysis)

          -  Pregnancy

          -  Patient under authorship or curators

          -  non-affiliation to a social security scheme
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Fabrice FERRE, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Toulouse</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Fabrice FERRE, MD</last_name>
    <phone>05 61 77 99 88</phone>
    <phone_ext>+33</phone_ext>
    <email>ferre.f@chu-toulouse.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>LAETITIA BOSCH, MD</last_name>
    <phone>05 61 77 99 80</phone>
    <phone_ext>+33</phone_ext>
    <email>bosch.l@chu-toulouse.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>UHToulouse</name>
      <address>
        <city>Toulouse</city>
        <zip>31059</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Fabrice FERRE, MD</last_name>
      <phone>05 61 77 99 88</phone>
      <phone_ext>+33</phone_ext>
      <email>ferre.f@chu-toulouse.fr</email>
    </contact>
    <investigator>
      <last_name>Fabrice FERRE, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Laeticia BOSCH, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>June 2019</verification_date>
  <study_first_submitted>May 28, 2019</study_first_submitted>
  <study_first_submitted_qc>June 5, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">June 7, 2019</study_first_posted>
  <last_update_submitted>June 5, 2019</last_update_submitted>
  <last_update_submitted_qc>June 5, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">June 7, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>anaesthetic modality</keyword>
  <keyword>Lung</keyword>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

